Vascular interventions/innovations and therapeutic advances (vita): IND enabling studies for a novel inhaled pdgf receptor inhibitor to treat PAH

Ended Definitive Contract Awarded Last action

Contract number
HHSN268201400013C
Awardee
Awarding agency
Obligated
$1,549,477

Award facts

Contract value 100% obligated
$1,549,476.97 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 31 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Slingerlands, NY 12159, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 $0
Other Administrative Action P00004 -$3,953
Exercise an Option 3 $618,547
Exercise an Option 2 $695,615
Other Administrative Action 1 $0
Original award $239,268

About this award

This is a Cost Plus Fixed Fee contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Pulmokine, Inc. for $1,549,476.97 to conduct IND-enabling studies for a novel inhaled PDGF receptor inhibitor to treat pulmonary arterial hypertension (PAH). The contract has no set-aside designation and was awarded on November 14, 2013, with a completion date of November 14, 2016. Pulmokine, Inc. is the prime contractor, and the contract is for a novel therapy to treat PAH.

Quick answers

Who was awarded contract HHSN268201400013C?

HHSN268201400013C was awarded to Pulmokine, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on November 14, 2013.

How much is contract HHSN268201400013C worth?

The government has obligated $1,549,477 on HHSN268201400013C.

Was contract HHSN268201400013C competed?

The extent of competition for HHSN268201400013C was full and open competition. The government received 31 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award